Keyphrases
Testicular Cancer
100%
Retroperitoneal Lymph Node Dissection (RPLND)
100%
Low Stage
100%
Germ Cell Tumors of the Testis
100%
Laparoscopic Retroperitoneal Lymph Node Dissection
100%
Paratesticular Rhabdomyosarcoma
66%
Chemotherapy
33%
Diagnostic Tool
16%
Patient Data
16%
Operative Time
16%
Lymph Node Ratio
16%
Estimated Blood Loss
16%
Oncologic
16%
Recurrent Disease
16%
Retrospective Chart Review
16%
Day Range
16%
Current Management
16%
Pathological Stage
16%
Hospital Stay
16%
Clinical Variables
16%
Open Procedure
16%
Diagnostic Performance
16%
Surgical Variables
16%
Minimally Invasive Approach
16%
Therapeutic Tool
16%
Operative Complications
16%
Management Options
16%
Post-chemotherapy
16%
Radical Orchiectomy
16%
Blood Transfusion Complication
16%
Medicine and Dentistry
Testis Cancer
100%
Retroperitoneal Lymph Node Dissection
100%
Testis Tumor
100%
Germ Cell
100%
Rhabdomyosarcoma
66%
Diagnosis
33%
Patient-Data
16%
Blood Transfusion
16%
Operation Duration
16%
Clinical Stage
16%
Bleeding
16%
Lymph Node
16%
Recurrent Disease
16%
Orchiectomy
16%
Operative Complication
16%
Retroperitoneal Disease
16%
Diseases
16%